These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29983335)

  • 21. Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain.
    Sullivan JA; Stanek LM; Lukason MJ; Bu J; Osmond SR; Barry EA; O'Riordan CR; Shihabuddin LS; Cheng SH; Scaria A
    Gene Ther; 2018 Jun; 25(3):205-219. PubMed ID: 29785047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adeno-associated virus (AAV) vectors in cancer gene therapy.
    Santiago-Ortiz JL; Schaffer DV
    J Control Release; 2016 Oct; 240():287-301. PubMed ID: 26796040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentiviral vectors in gene therapy: their current status and future potential.
    Escors D; Breckpot K
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):107-19. PubMed ID: 20143172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Future Looks Brighter After 25 Years of Retinal Gene Therapy.
    Auricchio A; Smith AJ; Ali RR
    Hum Gene Ther; 2017 Nov; 28(11):982-987. PubMed ID: 28825330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human gene therapy: a brief overview of the genetic revolution.
    Misra S
    J Assoc Physicians India; 2013 Feb; 61(2):127-33. PubMed ID: 24471251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction.
    Bennett J; Duan D; Engelhardt JF; Maguire AM
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2857-63. PubMed ID: 9418740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AAV Serotype Testing on Cultured Human Donor Retinal Explants.
    Buck TM; Pellissier LP; Vos RM; van Dijk EHC; Boon CJF; Wijnholds J
    Methods Mol Biol; 2018; 1715():275-288. PubMed ID: 29188521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simian immunodeficiency virus-based lentivirus vector for retinal gene transfer: a preclinical safety study in adult rats.
    Ikeda Y; Goto Y; Yonemitsu Y; Miyazaki M; Sakamoto T; Ishibashi T; Tabata T; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K
    Gene Ther; 2003 Jul; 10(14):1161-9. PubMed ID: 12833125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene Replacement Therapy for Inherited Retinal Dystrophies].
    Mühlfriedel R; Sothilingam V; Tanimoto N; Seeliger MW
    Klin Monbl Augenheilkd; 2017 Mar; 234(3):320-328. PubMed ID: 28355661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Therapy in Retinal Dystrophies.
    Ziccardi L; Cordeddu V; Gaddini L; Matteucci A; Parravano M; Malchiodi-Albedi F; Varano M
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An early history of gene transfer and therapy.
    Wolff JA; Lederberg J
    Hum Gene Ther; 1994 Apr; 5(4):469-80. PubMed ID: 8049304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light-driven cone arrestin translocation in cones of postnatal guanylate cyclase-1 knockout mouse retina treated with AAV-GC1.
    Haire SE; Pang J; Boye SL; Sokal I; Craft CM; Palczewski K; Hauswirth WW; Semple-Rowland SL
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3745-53. PubMed ID: 16936082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
    Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
    Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous.
    Dalkara D; Byrne LC; Klimczak RR; Visel M; Yin L; Merigan WH; Flannery JG; Schaffer DV
    Sci Transl Med; 2013 Jun; 5(189):189ra76. PubMed ID: 23761039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The growing clinical impact of gene therapy.
    Nienhuis A
    Mol Ther; 2008 Jun; 16(6):995-6. PubMed ID: 18500234
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution of adenoviruses as gene therapy vectors.
    Roy-Chowdhury J; Horwitz MS
    Mol Ther; 2002 Apr; 5(4):340-4. PubMed ID: 11945059
    [No Abstract]   [Full Text] [Related]  

  • 39. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs.
    Boyd RF; Sledge DG; Boye SL; Boye SE; Hauswirth WW; Komáromy AM; Petersen-Jones SM; Bartoe JT
    Gene Ther; 2016 Feb; 23(2):223-30. PubMed ID: 26467396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.